The Lung Cancer
Clinical Masterclass Series
Welcome to The Lung Cancer Clinical Masterclass Series which is co-chaired
by Hossein Borghaei and Ticiana Leal and boasts a faculty of 26 guest presenters who are leading clinicians within the lung cancer space.
13 episodes covering
26 current and emerging oncology topics
CME program delivered by 26 leading clinicians within the lung cancer space
13 CME credits for HCPs who watch all episodes and complete pre & post tests
Agenda and Faculty
Episode 1 – August 2024
Surgically resectable disease
Patrick Forde
Johns Hopkins University
(Baltimore, MD)
Topic: Neo-adjuvant studies
Jessica Donigton
UniversIty of Chicago (Chicago, Il)
Topic: Peri-operative studies
PUBLISHED – Click here to watch
Episode 2 – November 2024
Locally advanced NSCLC
Jhanelle Gray
Moffitt Cancer Centre (Tampa, FL)
Topic: Beyond the PACIFIC study
Sameera Kumar
Fox Chase Cancer Centre in
Philadelphia, PA
Topic: Novel perspectives in stage III
Episode 3 – December 2024
EGFR-mutant lung cancer
Suresh Ramalingam
Winship Cancer Institute (Altanta, GA)
Topic: First line treatment options
Zofia Piotrowska
Harvard Medical School (Boston, MA)
Topic: Treatment of patients with TKI-Resistant NSCLC
Episode 4 – January 2025
Novel stratergies in 2nd line and beyond NSCLC
Taofeek Owonikoko
University of Pittsburgh (Pittsburgh, PA)
Topic: Combination studies
Vincent Lam
Johns Hopkins University (Baltimore, MD)
Topic: Vaccines and Cellular therapies
Episode 4 – January 2025
Episode 5 – February 2025
Small cell lung cancer – extensive (ES) and Limited (LS)
Stephen Liu
Georgetown University (Washington, DC)
Topic: Limited stage
Lauren A, Byers
MD Anderson Cancer Center (Houston, TX)
Topic: Extensive stage
PUBLISHED – Click here to watch
Episode 6 – March 2025
Oncogenic fusions in lung cancer
Xiuning Le
Topic: MET, RET and NTRACK
Ibiayi Dagogo-Jack
Harvard Medical School
(Boston, MA)
Topic: ALK and ROS-1
PUBLISHED – Click here to watch
Episode 7 – May 2025
Blood-based detection and monitoring in lung cancer
Valsamo Anagnostou
Johns Hopkins University (Baltimore, MD)
Topic: Science and overview
Christian Rolfo
Ohio State University (Columbus, OH)
Topic: Clinical application
Episode 7 – May 2025
Episode 8 – June 2025
KRAS mutant lung cancers
Kathryn Arbour
Memorial Sloane Kettering Cancer Centre (New York, NY)
Topic: State of KRAS targeted therapy
Parth A. Desai
Fox Chase Cancer Center (Philadelphia, PA)
Topic: Novel agents and combination stratergies
Episode 9 – June 2025
New frontiers in lung cancer radiation therapy
Daniel Gomez
Memorial Sloane Kettering Cancer Centre (New York, NY)
Topic: Oligometastatic disease
Salma Jabbour
Cancer Institute of New Jersey (New Brunswick, NJ)
Topic: Combination strategies with immunotherapies
Episode 9 – June 2025
Episode 10 – July 2025
Lung cancer immunotherapy: Today
Charu Aggarwal
Perelman School of Medicine (Philadelphia, PA)
Topic: PDL-1 High
Jennifer Carlisle
Winship Cancer Institute (Altanta, GA)
Topic: PDL-1 Low / Negative
Episode 10 – July 2025
Episode 11 – July 2025
Lung cancer immunotherapy: Tomorrow
Julie Brahmer
Johns Hopkins University (Baltimore, MD)
Topic: Novel IO/IO combination
Scott Antonia
Duke University School of Medicine (Durham, NC)
Topic: TILs and cellular
Episode 11 – July 2025
Episode 12 – August 2025
Lung cancer screening and early detection
Denise Aberle
University of California (Los Angeles, CA)
Topic: How do we improve on early detection?
Lecia Sequist
Harvard Medical School (Boston, MA)
Topic: Implementation: Successes and lessons learned
Episode 12 – August 2025
Episode 13 – August 2025
Mesothelioma
Marjorie Zauderer
Westchester Medical Center (New York, NY)
Topic: First-Line Strategies for Pleural and Peritoneal Mesothelioma
Corey Langer
Perelman School of Medicine (Philadelphia, PA)
Topic: Strategies for Pre-Treated Mesothelioma: Current Standards and Future Directions
Episode 13 – August 2025
